Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
26 May, 2026, 04.38 PM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsFor the next few weeks, what needs to be watched is market breadth. And also look at which sectors are leading the rally. Why? Because, at ...
22 May, 2026, 12.18 AM IST
For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
20 May, 2026, 02.19 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
18 May, 2026, 10.31 PM IST
Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata MotorsIndian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...
14 May, 2026, 06.45 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
06 May, 2026, 11.19 PM IST
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
01 May, 2026, 11.01 PM IST
Eli Lilly to buy Ajax Therapeutics for up to $2.3 billionEli Lilly is set to acquire Ajax Therapeutics for a substantial sum. This move aims to develop a new oral treatment for myelofibrosis, a ra...
27 Apr, 2026, 04.41 PM IST
These large-, mid- and small-cap stocks can give more than 22% return in 1 year, according to analystsWhen a market is in a secular correction due to fears that the economy might take a hit for some reason, the fall is generally across the b...
24 Apr, 2026, 06.02 AM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
21 Apr, 2026, 05.59 AM IST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few days, as an investor you need to make a clear distinction on one front: Buying happening in a sector at a lower level, an...
17 Apr, 2026, 06.14 AM IST
For investors with ability to think beyond FY27: 5 mid-cap stocks from different sectors with an upside potential up to 33%The US blockade of the Strait of Hormuz, a claim by President Trump that negotiations are not dead in the water, and some tough talk from I...
14 Apr, 2026, 12.37 PM IST
Why did Prince Harry and Meghan Markle visit Royal Children's Hospital during their Australia tour? Watch the video of their ‘privately funded’ visitPrince Harry and Meghan, the Duke and Duchess of Sussex, visited Melbourne's Royal Children's Hospital on Tuesday, April 14, 2026. This mar...
14 Apr, 2026, 11.30 AM IST
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipelineGilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...
07 Apr, 2026, 08.58 PM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
07 Apr, 2026, 06.23 AM IST
5 stocks with consistent score improvement and upside potential of up to 26% in 1 year, according to analystsHere are three questions. First: When will the war end? Second: How long will it take to rebuild destroyed infrastructure? Third: How will ...
04 Apr, 2026, 05.51 AM IST
Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
05 Mar, 2013, 04.06 PM IST